Abstract
I read your June 26-July 2, 2010 issue, dedicated to diabetes, cover-to-cover, reviewed the cited references, and carefully studied The Lancet editorial. To my amazement, there was not one mention of metabolic/ bariatric surgery, the only proven method of resolving the clinical and laboratory manifestations of type 2 diabetes in about 80% of patients [1–4]. Though this technology is not suitable or available to all type 2 diabetics, it is an alternative for millions of people and, most importantly, metabolic/bariatric surgery is a clinical laboratory for diabetes research.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.